(Q43040757)

English

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.

scientific article published in October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

A M Di Bisceglie

1

1 reference

Europe PubMed Central

12 November 2017

R H Ghalib

2

1 reference

Europe PubMed Central

12 November 2017

F M Hamzeh

3

1 reference

Europe PubMed Central

12 November 2017

V K Rustgi

4

1 reference

Europe PubMed Central

12 November 2017

publication date

1 October 2007

1 reference

Europe PubMed Central

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

12 November 2017

14

1 reference

Europe PubMed Central

12 November 2017

10

1 reference

Europe PubMed Central

12 November 2017

721-729

1 reference

Europe PubMed Central

12 November 2017

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Hepatitis C: the clinical spectrum of disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Developments in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Pegylated interferons for the treatment of chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Hepatitis C viral dynamics: basic concept and clinical significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Liver transplantation in adults with acute liver failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00862.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2007.00862.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43040757&oldid=1590450480"